Gilead Sciences (GILD) Other Non-Current Assets (2009 - 2026)
Gilead Sciences' Other Assets was $4.75 billion in Q2 2026, up 17.9% from $4.03 billion a year earlier and up 4.3% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Other Assets at Gilead Sciences came in at $4.85 billion, up 28.5% from FY2024.
- Other Assets shows a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
- In earlier years, Other Assets was $3.77 billion in FY2024 (-21.3%), $4.79 billion in FY2023 (-0.2%), $4.8 billion in FY2022 (-3.3%) and $4.96 billion in FY2021 (-13.1%).
- Quarterly Other Assets has moved between $3.77 billion (Q4 2024) and $5.49 billion (Q3 2024) over five years.
- Compared with a year earlier, Other Assets has increased for three straight quarters, with growth averaging 2.7% over the last eight quarters.
- The best year-over-year quarter for Other Assets over five years was Q3 2024 (growth of 30.8%); the worst was Q1 2025 (a decline of 25.4%).
- Per Business Quant data, GILD's Other Assets in the three quarters before Q2 2026 was $4.55 billion (Q1 2026), $4.85 billion (Q4 2025) and $4.87 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 1.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.90 Bn |
| Jun 30, 2026 | 4.75 Bn |
| Mar 31, 2026 | 4.55 Bn |
| Dec 31, 2025 | 4.85 Bn |
| Sep 30, 2025 | 4.87 Bn |
| Jun 30, 2025 | 4.03 Bn |
| Mar 31, 2025 | 3.87 Bn |
| Dec 31, 2024 | 3.77 Bn |
| Sep 30, 2024 | 5.49 Bn |
| Jun 30, 2024 | 4.77 Bn |
| Mar 31, 2024 | 5.19 Bn |
| Dec 31, 2023 | 4.79 Bn |
| Sep 30, 2023 | 4.20 Bn |
| Jun 30, 2023 | 5.11 Bn |
| Mar 31, 2023 | 4.95 Bn |
| Dec 31, 2022 | 4.80 Bn |
| Sep 30, 2022 | 4.62 Bn |
| Jun 30, 2022 | 4.86 Bn |
| Mar 31, 2022 | 5.13 Bn |
| Dec 31, 2021 | 4.96 Bn |
API Access
Gilead Sciences Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();